Adolor and Pfizer Collaborate on Delta Opioid Agonists
By Business Review Editor
Pharma Deals Review: Vol 2008 Issue 91 (Table of Contents)
Published: 8 Jan-2008
DOI: 10.3833/pdr.v2008.i91.231 ISSN: 1756-7874
Section: Research & Development
Fulltext:
Abstract
Adolor and Pfizer entered into worldwide co-development agreement to develop and commercialize Adolor’s ADL5859 which is in phase 2 clinical trials for treating inflammatory pain associated with rheumatoid arthritis and acute post-dental surgery pain and ADL5747 which is in preclinical development for treating pain...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS